Roche to buy U.S. biotech firm InterMune for $8.3 billion

Roche Holding AG has agreed to buy U.S. biotech company InterMune Inc for USD8.3 billion in cash, marking the latest multibillion-dollar deal in a consolidating pharmaceutical sector.



from Zee News : Business http://ift.tt/1vBlQII

via IFTTT